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Introduction
To meet the requirements of an increasing biochemical
work-load, manufacturers have developed large and
expensive computer-controlled analytical systems. There-
fore the choice ofmain analyser for a clinical biochemistry
department is a major decision with long-term financial
implications. Advice is usually sought from current users,
but this is often more anecdotal than factual and certainly
not of a comparative nature. For many large depart-
ments, the choice is between two systems employing
different analyt!cal concepts. These are the Parallel
(American Monitor, UK) and a combination of the
SMAC2 and RA1000 analysers (Technicon, UK).
The Parallel is a recently introduced 30-channel, high-
capacity, discretionary analyser, whilst the SMAC2 is an
established 12-23 channel continuous-flow non-
discretionary analyser which can only be made selective
in terms of reporting. The RA1000 is a bench-top
discretionary analyser operating like the Parallel but with
much less capacity. The SMAC2 and RA1000 together
form a system of similar capability to the Parallel. With
both a Parallel and a SMAC2/RA1000 combination
installed in the authors’ separate departments in Leeds, a
study has been undertaken to provide comparative data
which should aid potential purchasers.
A SMAC2 was installed in the Chemical Pathology
Department of the Leeds General Infirmary (LGI) in
September 1982, followed by an RA1000 in October
1983. A Parallel was installed in the Chemical Pathology
Department of St. James’s University Hospital in Janu-
ary 1984. Both laboratories have a similar annual
work-load and serve similar populations. The 15-week
period of the evaluation took place during October to
December 1984 against a background of normal routine
service work. The analytical performance, reliability and
running costs of both systems were investigated over this
period.
* Present address: Pathology Department, Riyadh Armed Forces
Hospital, PO Box 7897, Riyadh 11159, Saudi Arabia.
Methods
All methodologies used were as recommended by the
manufacturers. For the assessment of analytical perfor-
mance, sufficient quantities of unassayed Gibcotrol
(Gibco Diagnostics) freeze-dried control material at three
nominal levels (Low: lot No. 194; Normal: lot No. 235;
High: lot No. 191) were purchased. Wellcomtrol (Well-
come Reagents Ltd) SMAC High (lot No. K7519) was
used on the Parallel for an elevated alkaline phosphatase
level because of the analytical unsuitability of the
Gibcotrol High material.
On one day a week, over a period of 15 weeks, each
laboratory reconstituted one bottle of each material. The
contents of the bottles were analysed randomly 10 times
throughout the day for the commonly requested tests (see
table 1). On each subsequent week the day was advanced
by one in order that each of the five working days were
covered on three occasions. For tests less frequently
assayed, two aliquots of each material were measured
during one analytical run per week (see table 2).
For the investigation of reliability, a detailed log of the
daily working parameters, electromechanical and other
failures were recorded throughout the whole three-month
period. The relative running costs ofthe two systems were
calculated for the whole of 1984, including staff, con-
sumables and maintenance contracts.
Results
Analytical performance
The values obtained on the quality-control materials
were analysed using the Statistics Package for Social
Sciences (SPSS). Analysis ofvariance on the data showed
that significant imprecision was between, rather than
within, analytical runs. For each test, the overall mean,
standard deviation and coefficient ofvariation is given in
tables and 2. Results are shown only for those tests
common to both systems and where a test level was close
to the detection limit of the assay, the results have been
excluded from the tables. The data were reanalysed after
removal of possible outliers using Healy’s procedure [1]
and the recalculated coefficients ofvariation are shown in
brackets in tables and 2.
Costs
Details of capital costs can be found in a comprehensive
review of large analysers based on manufacturers’
information [2]. An estimate ofthe 1984 running costs for
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Table 1. Analysis of150 measurements made on 15 days over a period of15 weeks.
SMAC2 Parallel
Test Mean SD CV
Sodiummmol/1 L 123"2 1"16 0"9 (0"7)
N 143.3 0’91 0"6 (0’6)
H 150"6 1"20 0.8 (0"8)
Potassium mmol/1 L 2"24 0"082 3"7 (3"3)
N 4’08 0"116 2"8 (2"9)
H 6"52 0"181 2"8 (2"6)
Chloridemmol/l L 85"9 0"97 1.1 (1"0)
N 102.0 0"92 0’9 (0"7)
H 106.3 1"04 1"0 (0"9)
Bicarbonatemrnol/1 L 11.7 0"60 5"1 (4"4)
N 24"8 0’79 3-2 (2"9)
H 36"6 1.07 2"9 (2"9)
Urea mmol/1 L 1"75 0"16 9.1 (7"7)
N 5"27 0.14 2’7 (2"3)
H 26.77 0.44 1.6 (1.7)
Creatinineumol/1 L 111"8 3"03 2"7 (2"7)
N 105"2 3.11 3’0 (2"7)
H 611.5 8.96 1.5 (1.4)
Total protein g/1 L 41"7 0"95 2"3* (2’3)*
N 75.0 1.00 1.3 (1.2)
H 90.7 1.34 1.5 (1.4)*
Albuming/1 L 21"0 0.44 2’1 (0"7)
N 39.5 0.67 1.7 (1.4)
H 46.0 0.68 1.5 (3.8)
Bilirubin umol/1 N 9" 0"88 9"6 (7" 1)
H 168’0 6"65 4"0* (4.1)*
Alk. Phos. K.A.U/dl N 6"55 0’230 3"5 (3"6)
H 20"74 0"660 3"2* (2"7)*
Calciummmol/1 L 1"661 0"026 1"6 (1"4)
N 2.516 0.030 1.2 (1.1)
H 3.422 0.046 1.3 (1.3)
Phosphate mmol/1 L 0"856 0"022 2"6 (2"3)
N 1"128 0"025 2"2* (2"0)
H 2"832 0"111 3"9* (3.4)
Mean
124"5
144"3
!51.0
2.09
4.23
6.68
83.6
104.3
110.6
11.0
23.4
35.6
2"24
6.05
26.01
111.9
100.0
576.9
41.1
71.0
80.6
20.8
39.3
44.3
10.2
166.4
4.29
30.15
1.755
2.485
3.255
0.916
1.107
2’937
SD
1.99
1.99
2.07
0.050
0.167
0.100
2.37
2.55
2.84
1.74
1.79
3.46
0.33
0.36
0.91
10.83
14.21
15.20
1.05
1.91
3.75
1.60
1.41
1.36
2"21
6"72
1.890
1.089
0.043
0.041
0.094
0"035
0.021
0"101
CV
1.6 (1.4)
1.4 (1.2)
1.4 (1.3)
24 (1.5)
4.0 (1.5)
1.5 (1.3)
2.8 (2.0)
2.4 (1.8)
2"6 (1.9)
15.8 (10.3)
7.7 (4.7)
9.7 (7.5)
14.7 (13.2)
6.0 (5.9)
3.5 (2.3)
9.7 (8.2)
14.2 (9.0)
2.6 (2.4)
2.6* (2.0)*
2-7 (1.8)
4.6 (1.6)*
7.7 (5.1)
3.6 (3.3)
3. (.o)
21.6 (17.3)
4.0* (3.7)*
44.8 (5.3)
3.6* (3.2)*
2.4 (2.2)
1.6 (1.5)
2.9 (1.8)
3.8 (1.7)
1.9" (1.4)
3.4* (1.5)
L Gibco Low N Gibco Normal H Gibco High.
Figures in brackets are CV’s after exclusion of outliers.
* Imprecisions of the analysers not significantly different (P > 0’05).
both systems is shown in table 3. Staffing costs are based
on 1"2 times the mid-point ofthe appropriate salary scale.
In the two laboratories similar functions are performed
by different grades of staff. At St James’s, demographic
and test scheduling are performed by MLSOs, in contrast
to clerical staff at the LGI. Furthermore, all samples for
the Parallel are separated by the Parallel staff, whilst at
the LGI samples for the SMAC2/RA1000 are processed
by reception staff. These procedural differences have
been allowed for by calculating the number ofclerical and
reception staff at the LGI employed on direct SMAC2/
RA1000 work on a pro rata basis.
Reliability
Data collected throughout the three-month period on the
work-load and reliability are given in table 4.
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Discussion
The Parallel was designed to operate in a completely
selective discretionary mode. However, at St. James’s
Hospital, because of a reluctance by clinical staff to
request tests individually, three main profiles for urea and
electrolytes, liver function and bone were offered, whilst
remaining tests were measured individually. The order in
which the samples were analysed was found to be
important because, prior to any test analysis,, appropriate
reagent lines were purged ifnot immediately preceded by
another analysis for the same test. This meant that the
reagent consumption was much higher than expected and
necessitated the grouping of the expensive tests where
possible: either within the analytical run or on a less
frequent batch basis. In particular, the high cost of the
bicarbonate reagent discourages the dispersion of non-A. J. Little et al. Comparison of Technicon and American Monitor Systems
Table 2. Analysis of30 measurements made on 15 .days over a period of 15 weeks.
RA1000 Parallel
Test mean SD CV Mean SD CV
ALT IU/1 L 14.2 2.4
N 23.9 1.7
H 159.3 9.5
Uric acid umol/1 L 0" 143 0.007
H 0’345 0"016
H 0"569 0"022
Triglyceride mmol/1 N 0"29 0" 19
H 0"52 0’28
Cholesterol mmol/l L 2"28 0"05
N 4.13 0’09
H 8-73 0.16
Creatine kinase IU/1 L 17"0 1.0
N 35’4 3.4
H 191.4 8.8
17"0 (15"0)
6"9 (6.7)
0.5 (a.)
4.9 (5.0)
4.6* (2.6)
3.9* (3.2)*
63.7 (11.6)
53.8 (5.4) . (.0) . (.0)
1.9 (1.8)
6.2 (6.2),
9.5 (8.3)
4.6 (4.6)*
8.9
16.5
129.3
0.103
0.287
0.529
0.32
0.45
2.18
3.65
7.43
24.5
78.3
439.4
4.9
4.1
6.8
0.018
0.012
0.018
0.12
0.12
0.36
0.54
1.19
11.5
17.4
27.1
54.6 (38.0)
24.8 (23.9)
5.a (5.)
17.5 (15.7)
4.2* (3.9)
3"4* (3"2)*
35"5
26"9
16"3
14"7
18"2
47"2
22"3
6"2
(31.1)
(26.1)
(13.8)
(11.3)
(12.7)
(47.1)
(20.9)
(5.)*
L- Gibco Low N Gibco Normal H Gibco High.
Figures in brackets are CVs after exclusion of outliers.
* Imprecisions of the analysers not significantly different (P > 0"05).
Table 3. Annual running costs.
Item SMAC2/RA1000 Parallel
Maintenance 25 305 20 300
Staffing 46 254 42 496
Dry consumables 15 522 4 002
Reagents 9230 27 921
Calibrators and controls 5663 3709
Total requests 99 124 80 636
Total tests 122 192 582 960
Total cost (-staff) 55 720 55 932
Total cost (+staff) 101 974 98 428
Table 4. Analyser work-load and reliability data.
SMAC2 Parallel
Observed Observed
Mean range Mean range
Time lst result (24 h) 10.24 9.55-11.30 12"57 11.00-16.10
Time last result (24 h)15"56 14.55-17.35 16"55 15.30-20"00
Total cups sampled 601 415-779 471 296-665
Total Q.C. cups 50 35-62 78 30-197
Patient samples 473 343-616 363 176-590
Repeat analyses 62 30-192 26 0-140
Dilutions 16 6-35 0-6
% Samples re-run 16"8 9"4-56"5 7.7 0-57
Routine maintenance
per week (minutes) 36 20-90 76 60-120
Extra maintenance
per week (minutes) 11 0-30 99 45-189
Downtime per week
(minutes) 47 0-220 117 15-420
electrolyte samples between those requiring bicarbonate.
The Parallel was therefore operated in a mode not
originally envisaged. At the LGI, a 12-channel SMAC
profile (see table 1) was used for the analysis of the
majority of samples. The other tests (see table 2) were
measured on the RA1000 in batches.
Precision
During the study period both the SMAC2 and RA1000
performed better than the Parallel and the latter’s
imprecision did not greatly improve on exclusion of
possible outliers. These findings for the SMAC2 are in
accordance with data published in the Wellcome Quality
Assurance Scheme end-of-term report (October 1985),
which shows that the SMAC2 analyser group have lower
imprecisions than the Parallel group for corresponding
Table 5. Wellcome quality control scheme six-month imprecision
valuesfor the St. James’s Hospital Parallel. (Six pairs.)
Period
May 85- November 84-
October 85 March 85
Test Units
Albumin g/1
Bicarbonate mmol/1
Bilirubin umol/1
Calcium mmol/1
Chloride mmol/1
Cholesterol mmol/1
Creatinine umol/1
Phosphate mmol/1
Potassium mmol/1
Protein mmol/l
Sodium mmol/1
Triglyceride mmol/1
Urea mmol/1
Uric acid umol/1
ALT IU/1
CK IU/1
Imprecisions
1"19 1.08
0"99 1"22
1"03 3"77
0"046 0"093
2"08 2"22
0.136 0"297
13"7 7"4
0.035 0-045
0.055 0.057
1.12 1.91
2"20 1.24
0.153 0.182
0.36 0.71
0.014 0.024
2.05 3.86
15.4 52.0
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channels. However, the report shows the RA1000 and
Parallel groups to be more comparable, which is not
reflected in our data. Since the period of the comparison
the performance of the St. James’s Parallel has improved,
reflected by external quality assurance scheme returns
(table 5).
Reliability
There were considerable problems with the mechanical
reliability of the Parallel during the period of evaluation,
the instrument being totally unusable on two full days.
The problems were due to a computer failure necessitat-
ing a replacement computer being installed overnight by
American Monitor, and, secondly, an electromechanical
failure in the vial wash system. A further major contribu-
tion to the excessive downtime was the occasional halting
of the Parallel during analysis due to a communications
failure between the two system computers (this has been
rectified by American Monitor). The downtime of the
SMAC2 was predominantly due to replacing membranes
during a run. The RA1000 downtime was approximately
15 min per week and was contributed to by lamp and
sample probe problems.
Costings
In this study, during which little discretionary requesting
was exercised or encouraged in either hospital, the total
cost ofrunning the two systems was very similar. Because
of the considerable difference in the way the two hospitals
handle similar work-loads, comparison of overall cost of
service is more appropriate. Theoretically it might seem
to be possible to reduce the overall cost at St. James’s
Hospital by encouraging a higher degree of selectivity in
requests but as previously stated, this would be countered
by increased reagent costs.
Summary
Since our evaluation, there have been continuing in-the-
field developments of the Parallel, in both hardware and
software, which have improved the general performance
of the instrument. Performance is also associated with
operator familiarity with the instrument and the running-
in time of a new instrument must not be underestimated.
However, from the present study it is concluded that,
overall, the SMAC2/RA1000 combination is more reli-
able and less imprecise than the Parallel.
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SCIENTIFIC COMPUTING AND
AUTOMATION
13 to 15 May 1987: Amsterdam, The Netherlands.
Europe’s first conference specifically for
computing and automation in the sciences will
be held in Amsterdam in May 1987. Established
as the European counterpart of its successful
sister meeting in the USA, Scientific Computing
and Automation (Europe) SCAEUROPE-
will be supported by a number of European
societies, among them the Royal Society of
Chemistry, UK, and the Royal Dutch Chemical
Society. A full scientific programme, set up by a
scientific board under the chairmanship of
Professor D. L. Massart ofthe Vrije Universiteit,
Brussels, will form the backbone of the meeting.
A number of short courses will be run in
conjunction with the conference and a full
exhibition of products and services, with special
sessions on new developments, will also be
included. It is intended that participants be
provided with suitable computer facilities for
’hands-on’ interface with exhibitors and other
participants.
SCA Europe will devote both its inter-
disciplinary and specialist parallel sessions to the
latest advances in computing and automation in
the scientific environment, including:
Chemistry (pharmaceutical, analytical,
environmental, synthesis).
The life sciences (clinical, microbiological.
Engineering & technology (biotechnology,
chemical technology).
Within the framework of these specialist fields,
members of the international scientific
community will be able to share and build upon
their experiences in
Computing: off-the-shelf software, databases,
image analysis, computer-aided learning
(CAL), pattern recognition, computer-
assisted organic synthesis, molecular modell-
ing, computational chemistry, chemometrics,
etc.
Automation: LIMS, networking, data
acquisition, sensors and microsensors, process
control, impact of new hardware on the
laboratory, etc.
Robotics- laboratory products. Artificial
intelligence and expert systems.
Details from Scientific Computing and Automation
(Europe), c/o Reunion International B V, Tholenseweg
3, 1/81 KD Amstelveen, The Netherlands. Tel.: 020 43
2545.
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